tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

ADVM Stock Latest News

Adverum Biotechnologies to Participate in the Jefferies Healthcare Conference
Press ReleasesAdverum Biotechnologies to Participate in the Jefferies Healthcare Conference
2d ago
ADVM
Adverum Biotechnologies Announces New Executive Leadership Roles
Press ReleasesAdverum Biotechnologies Announces New Executive Leadership Roles
10d ago
ADVM
Adverum Biotechnologies Presents Nonclinical Data in Support of Ixo-vec’s Phase 2 Clinical Development at ASGCT 2023 Annual Meeting
Press ReleasesAdverum Biotechnologies Presents Nonclinical Data in Support of Ixo-vec’s Phase 2 Clinical Development at ASGCT 2023 Annual Meeting
17d ago
ADVM
ADVM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsADVM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
ADVM
Adverum Biotechnologies Announces Upcoming Data Presentations at ASGCT 2023 including Data on a New Intravitreal (IVT) Geographic Atrophy Secondary to Dry AMD
Press ReleasesAdverum Biotechnologies Announces Upcoming Data Presentations at ASGCT 2023 including Data on a New Intravitreal (IVT) Geographic Atrophy Secondary to Dry AMD
1M ago
ADVM
Adverum Biotechnologies presents nonclinical data at 2023 ARVO meeting
The FlyAdverum Biotechnologies presents nonclinical data at 2023 ARVO meeting
1M ago
ADVM
Adverum Biotechnologies Presents Nonclinical Data at the 2023 ARVO Annual Meeting Supporting Potential for Staggered Bilateral Administration of Ixo-vec
Press ReleasesAdverum Biotechnologies Presents Nonclinical Data at the 2023 ARVO Annual Meeting Supporting Potential for Staggered Bilateral Administration of Ixo-vec
1M ago
ADVM
Adverum Biotechnologies granted ILAP designation for Ixo-vec in Wet AMD
The FlyAdverum Biotechnologies granted ILAP designation for Ixo-vec in Wet AMD
2M ago
ADVM
Adverum Biotechnologies Granted Innovative Licensing and Access Pathway Designation in the United Kingdom for Ixo-vec for the Treatment of Wet AMD
Press ReleasesAdverum Biotechnologies Granted Innovative Licensing and Access Pathway Designation in the United Kingdom for Ixo-vec for the Treatment of Wet AMD
2M ago
ADVM
Adverum Biotechnologies Announces Upcoming Nonclinical Data Presentation Supporting Staggered Bilateral Administration of Ixoberogene Soroparvovec (Ixo-vec) at the 2023 ARVO Annual Meeting
Press ReleasesAdverum Biotechnologies Announces Upcoming Nonclinical Data Presentation Supporting Staggered Bilateral Administration of Ixoberogene Soroparvovec (Ixo-vec) at the 2023 ARVO Annual Meeting
2M ago
ADVM
Adverum Biotechnologies reports Q4 EPS (33c), consensus (36c)
The FlyAdverum Biotechnologies reports Q4 EPS (33c), consensus (36c)
2M ago
ADVM
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
Press ReleasesAdverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
2M ago
ADVM
Adverum Biotechnologies initiated with a Buy at Ladenburg
The FlyAdverum Biotechnologies initiated with a Buy at Ladenburg
3M ago
ADVM
Adverum Biotechnologies to Present at Upcoming Investor Conferences
Press ReleasesAdverum Biotechnologies to Present at Upcoming Investor Conferences
3M ago
ADVM
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesAdverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5M ago
ADVM
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesAdverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6M ago
ADVM
Adverum Biotechnologies reports Q3 EPS (40c) consensus (34c)
The FlyAdverum Biotechnologies reports Q3 EPS (40c) consensus (34c)
7M ago
ADVM
Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-vec (ADVM-022)
Press ReleasesAdverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-vec (ADVM-022)
7M ago
ADVM
Adverum Biotechnologies Announces Upcoming Data Presentation at The Retina Society Annual Meeting
Press ReleasesAdverum Biotechnologies Announces Upcoming Data Presentation at The Retina Society Annual Meeting
7M ago
ADVM
Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-vec (ADVM-022) in the OPTIC Study in Wet AMD
Press ReleasesAdverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-vec (ADVM-022) in the OPTIC Study in Wet AMD
8M ago
ADVM
Adverum Biotechnologies to Participate in the Chardan 6th Annual Genetic Medicines Conference
Press ReleasesAdverum Biotechnologies to Participate in the Chardan 6th Annual Genetic Medicines Conference
8M ago
ADVM
Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit
Press ReleasesAdverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit
8M ago
ADVM